CMS Plans $1 Billion in Lab Fee Schedule Cuts for 2027 and What It Means for Your Practice

Quick Answers

As of September 2026, CMS has announced plans to better align the 2027 Clinical Laboratory Fee Schedule (CLFS) rates with private sector payment rates, a change the agency estimates will save approximately $1 billion. CMS highlighted this development in its September 24, 2026 MLN Connects newsletter and has opened a comment period with a deadline of October 21, 2026. For medical practices that bill lab tests under Medicare, this represents a significant reduction in reimbursement that will affect revenue starting in January 2027.

• Scale of the cut: CMS estimates the rate alignment will reduce Medicare lab payments by approximately $1 billion, affecting practices across all specialties that perform and bill laboratory testing.
• Comment deadline: Practices and billing companies can submit comments on the preliminary payment determinations for new lab tests and request reconsideration of certain Medicare Administrative Contractor gapfill recommendations through October 21, 2026.
• Effective date: The 2027 CLFS rates, once finalized, take effect January 1, 2027. Practices should begin modeling the revenue impact now rather than waiting for the final rates.

What CMS Announced on September 24

CMS used its September 24, 2026 MLN Connects newsletter to announce that it plans to better align the 2027 Clinical Laboratory Fee Schedule rates with private sector payment rates. The agency framed the change as a measure to stop payments above market rates for laboratory services in Medicare and save taxpayer dollars.

The estimated savings of $1 billion signals a significant downward adjustment to the rates that practices and independent laboratories currently receive for Medicare lab work. CMS has also posted the preliminary payment determinations and opened a formal comment window through October 21, 2026, during which practices, billing companies, and laboratory stakeholders can submit feedback or request reconsideration of specific rate recommendations from Medicare Administrative Contractors.

This announcement comes alongside the October 2026 Medicare Part B Drug Pricing Files update, which was also released in September. Combined with the FY 2027 ICD-10-CM code changes taking effect October 1 and the ongoing 2027 Physician Fee Schedule proposed rule, practices are facing a compressed timeline of overlapping billing and reimbursement changes heading into the new year.

Does the Lab Fee Schedule Cut Affect Your Practice?

The CLFS rate reduction affects every medical practice that performs and bills laboratory tests under Medicare Part B. This includes primary care, internal medicine, family medicine, urgent care, and virtually every specialty that orders or performs in-office lab work. Independent clinical laboratories, reference laboratories, and hospital outpatient labs are also directly affected.

One question we hear constantly from practice managers is whether billing changes that target laboratories also affect the physician practice. The answer is yes, if your practice performs CLIA-waived tests, point-of-care testing, or any in-office lab work that you bill under the CLFS. Common examples include rapid strep tests, urinalysis, glucose monitoring, hemoglobin A1C, basic metabolic panels, and rapid flu or COVID tests. If your practice bills any of these under Medicare, the 2027 rate reduction will reduce what you receive per test.

Practices that send all lab work to external reference laboratories may see indirect effects. If the reference lab absorbs a significant payment cut, it may adjust its pricing to the practice, reduce its service scope, or change its turnaround commitments. The downstream effects of a $1 billion system-wide cut do not stop at the lab’s front door.

Why CMS Is Cutting Lab Rates

CMS has signaled for several years that it believes the CLFS overpays for certain laboratory services relative to what private sector payers reimburse for the same tests. The Protecting Access to Medicare Act (PAMA) of 2014 set the framework for aligning CLFS rates with private payer rates by requiring laboratories to report their private payer data to CMS. That reporting process has been contentious, with multiple delays, data collection challenges, and industry pushback over which labs are required to report.

The 2027 rate adjustment represents CMS’s latest effort to close the gap between Medicare lab payments and commercial market rates. The agency argues that paying above market rates increases costs for taxpayers and Medicare beneficiaries without improving the quality of laboratory services. For practices, the practical consequence is lower reimbursement per test, which directly affects revenue for in-office lab work. Combined with the proposed 2027 modifier 25 payment reduction and the Physician Fee Schedule conversion factor cut, the overall direction for 2027 Medicare payments is down across multiple revenue categories.

What to Do Before the October 21 Deadline

If your practice bills lab tests under Medicare, these steps will help you prepare for the 2027 CLFS rate changes and protect your revenue.

1. Pull a report of every lab test your practice billed under Medicare in the last 12 months, sorted by CPT or HCPCS code and payment volume. This identifies which tests carry the highest revenue exposure if rates drop.
2. Review the CMS preliminary payment determinations for 2027, available on the CMS Medicare Part B Drug and Lab Fee Schedule pages. Compare the proposed rates against what you currently receive for your highest-volume tests.
3. Model the revenue impact. Multiply your volume per test by the difference between your current rate and the proposed 2027 rate. This gives you a dollar figure for the expected reduction, which is what you need for budgeting and staffing decisions.
4. Submit a comment to CMS before October 21, 2026, if any of the preliminary rates appear to be based on inaccurate data or if your MAC’s gapfill recommendation does not reflect the actual cost of performing a test. Comments carry more weight when they include specific volume data and cost documentation.
5. Evaluate whether in-office testing remains financially viable for lower-reimbursement tests. Some practices may find that sending certain tests to a reference lab is more cost-effective than absorbing the operational overhead of performing them in-house at reduced rates.
6. Verify that your billing team is capturing every allowable lab charge and submitting clean claims. A rate cut makes it even more important to eliminate missed charges, incorrect coding, and preventable denials on the lab claims you do submit.

Common Mistakes After Fee Schedule Cuts

Across the billing companies we vet, a recurring pattern after a fee schedule reduction is that practices react to the revenue drop without first auditing whether they are capturing everything they are entitled to bill. Before assuming the only option is to absorb lower rates, check for these common issues.

• Missed charges. If your practice performs a panel of tests during a visit and only bills the panel code, individual component tests that could be billed separately under certain payer rules may be going unbilled. This is especially common with CLIA-waived tests performed alongside a standard lab panel.
• Incorrect code assignment. Billing a less specific code when a more specific code exists can result in a lower payment even before the rate cut takes effect. Make sure your coders are using the most current CPT and HCPCS codes for every test performed.
• Documentation gaps. If a lab test is denied for medical necessity, the issue is almost always in the documentation, not in the test itself. The ordering provider’s note must support why the test was medically necessary for that patient on that date. This is a pattern we see regularly across the providers who come to us after experiencing a spike in lab denials. Accurate documentation paired with proper diagnosis coding is the foundation of clean lab billing.

In-House vs. Outsourced Lab Billing

For practices that perform a high volume of in-office lab work, the 2027 CLFS rate cut adds pressure to an already thin-margin billing operation. In-house billing teams at smaller practices often lack the bandwidth to monitor fee schedule changes, model revenue impact, submit comments during CMS open periods, and adjust charge capture workflows before the new rates take effect.

An outsourced billing company that manages lab billing for multiple practices has a structural advantage here. The fee schedule analysis, rate modeling, and workflow updates happen once across the entire client base rather than once per practice. The billing company also has direct visibility into denial patterns across payers and can identify coding or documentation issues that an in-house team with limited comparative data might miss.

Providers often come to us after a rate cut because their in-house team did not catch the change until the first month of reduced payments arrived. By that point, the revenue loss is already accumulating and the rework needed to adjust workflows is competing with daily billing operations. Getting matched with a billing company before the January 2027 effective date gives your practice time to prepare rather than react.

Frequently Asked Questions

Next Steps